Folate receptor alpha as a tumor target in epithelial ovarian cancer

Kimberly R. Kalli(Mayo Clinic), Ann L. Oberg(Mayo Clinic), Gary L. Keeney(Mayo Clinic), Teresa J. Christianson(Mayo Clinic), Philip S. Low(Purdue University Institute for Cancer Research), Keith L. Knutson(Mayo Clinic), Lynn C. Hartmann(Mayo Clinic in Arizona)
Gynecologic Oncology
January 31, 2008
10.1016/j.ygyno.2007.11.020
Cited by 461Open Access
Full Text

Abstract

Related Papers

Cancer of the Ovary
S A Cannistra|New England Journal of Medicine|2004|2.2k
Principles and Practice of Gynecologic Oncology
William J. Hoskins, Carlos A. Pérez, Robert C. Young|Unknown|1992|948
Differential regulation of folate receptor isoforms in normal and malignant tissues in vivo and in established cell lines. Physiologic and clinical implications
John F. Ross, P. K. Chaudhuri, Manohar Ratnam|Cancer|1994|888
Folate-binding protein is a marker for ovarian cancer.
Ian Campbell, T. Alwyn Jones, William D. Foulkes et al.|PubMed|1991|459
Guidelines and selection criteria for secondary cytoreductive surgery in patients with recurrent, platinum‐sensitive epithelial ovarian carcinoma
S. Dennis, Kristina McCaughty, John P. Diaz et al.|Cancer|2006|355